338 related articles for article (PubMed ID: 21865642)
1. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Valentino MA; Lin JE; Snook AE; Li P; Kim GW; Marszalowicz G; Magee MS; Hyslop T; Schulz S; Waldman SA
J Clin Invest; 2011 Sep; 121(9):3578-88. PubMed ID: 21865642
[TBL] [Abstract][Full Text] [Related]
2. Uroguanylin: how the gut got another satiety hormone.
Seeley RJ; Tschöp MH
J Clin Invest; 2011 Sep; 121(9):3384-6. PubMed ID: 21865649
[TBL] [Abstract][Full Text] [Related]
3. Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesity.
Kim GW; Lin JE; Snook AE; Aing AS; Merlino DJ; Li P; Waldman SA
Nutr Diabetes; 2016 May; 6(5):e211. PubMed ID: 27214655
[TBL] [Abstract][Full Text] [Related]
4. GUCY2C: at the intersection of obesity and cancer.
Kim GW; Lin JE; Waldman SA
Trends Endocrinol Metab; 2013 Apr; 24(4):165-73. PubMed ID: 23375388
[TBL] [Abstract][Full Text] [Related]
5. Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C.
Romi H; Cohen I; Landau D; Alkrinawi S; Yerushalmi B; Hershkovitz R; Newman-Heiman N; Cutting GR; Ofir R; Sivan S; Birk OS
Am J Hum Genet; 2012 May; 90(5):893-9. PubMed ID: 22521417
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of uroguanylin and guanylin in vivo.
Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
[TBL] [Abstract][Full Text] [Related]
7. GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
Li P; Wuthrick E; Rappaport JA; Kraft C; Lin JE; Marszalowicz G; Snook AE; Zhan T; Hyslop TM; Waldman SA
Cancer Res; 2017 Sep; 77(18):5095-5106. PubMed ID: 28916678
[TBL] [Abstract][Full Text] [Related]
8. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
Lin JE; Colon-Gonzalez F; Blomain E; Kim GW; Aing A; Stoecker B; Rock J; Snook AE; Zhan T; Hyslop TM; Tomczak M; Blumberg RS; Waldman SA
Cancer Res; 2016 Jan; 76(2):339-46. PubMed ID: 26773096
[TBL] [Abstract][Full Text] [Related]
9. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Lin JE; Li P; Snook AE; Schulz S; Dasgupta A; Hyslop TM; Gibbons AV; Marszlowicz G; Pitari GM; Waldman SA
Gastroenterology; 2010 Jan; 138(1):241-54. PubMed ID: 19737566
[TBL] [Abstract][Full Text] [Related]
10. Guanylyl cyclase C signaling axis and colon cancer prevention.
Pattison AM; Merlino DJ; Blomain ES; Waldman SA
World J Gastroenterol; 2016 Sep; 22(36):8070-7. PubMed ID: 27688649
[TBL] [Abstract][Full Text] [Related]
11. Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.
Blomain ES; Merlino DJ; Pattison AM; Snook AE; Waldman SA
Mol Pharmacol; 2016 Sep; 90(3):199-204. PubMed ID: 27251363
[TBL] [Abstract][Full Text] [Related]
12. Guanylin peptides: cyclic GMP signaling mechanisms.
Forte LR; Freeman RH; Krause WJ; London RM
Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
[TBL] [Abstract][Full Text] [Related]
13. Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21.
Basu N; Saha S; Khan I; Ramachandra SG; Visweswariah SS
J Biol Chem; 2014 Jan; 289(1):581-93. PubMed ID: 24217248
[TBL] [Abstract][Full Text] [Related]
14. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.
Gibbons AV; Lin JE; Kim GW; Marszalowicz GP; Li P; Stoecker BA; Blomain ES; Rattan S; Snook AE; Schulz S; Waldman SA
Cancer Res; 2013 Nov; 73(22):6654-66. PubMed ID: 24085786
[TBL] [Abstract][Full Text] [Related]
15. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.
Yarla NS; Gali H; Pathuri G; Smriti S; Farooqui M; Panneerselvam J; Kumar G; Madka V; Rao CV
Semin Cancer Biol; 2019 Jun; 56():168-174. PubMed ID: 30189250
[TBL] [Abstract][Full Text] [Related]
16. Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis.
Garin-Laflam MP; Steinbrecher KA; Rudolph JA; Mao J; Cohen MB
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G740-9. PubMed ID: 19221018
[TBL] [Abstract][Full Text] [Related]
17. Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin.
Merlino DJ; Barton JR; Charsar BA; Byrne MD; Rappaport JA; Smeyne RJ; Lepore AC; Snook AE; Waldman SA
Brain Struct Funct; 2019 Nov; 224(8):2983-2999. PubMed ID: 31485718
[TBL] [Abstract][Full Text] [Related]
18. The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
Wilson C; Lin JE; Li P; Snook AE; Gong J; Sato T; Liu C; Girondo MA; Rui H; Hyslop T; Waldman SA
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2328-37. PubMed ID: 25304930
[TBL] [Abstract][Full Text] [Related]
19. Guanylate Cyclase C: A Current Hot Target, from Physiology to Pathology.
Uranga JA; Castro M; Abalo R
Curr Med Chem; 2018; 25(16):1879-1908. PubMed ID: 29210639
[TBL] [Abstract][Full Text] [Related]
20. Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent.
Steinbrecher KA; Mann EA; Giannella RA; Cohen MB
Gastroenterology; 2001 Nov; 121(5):1191-202. PubMed ID: 11677212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
